Global Healthcare CMO Market to Reach US$246.5 bn by 2019

Sweeping Reforms in Healthcare Sector will Create Multibillion-dollar Opportunities for Healthcare Contract Manufacturing Outsourcing Market, reports TMR Increasing competition in the healthcare sector has impelled major companies to concentrate on the reformation of their business strategies along with the emphasis on product manufacturing, development, design, and marketing, reports Transparency Market Research in a new study.

In this regard, contract manufacturing outsourcing has become a major need for the manufacturers of pharmaceuticals and medical devices as they strive to retain their position in the market. The top three companies in the global healthcare CMO market acquire approximately 17.2% of the global revenue with Catalent Pharma Solutions Inc. leading. The company was trailed by Lonza Group and Boehringer Ingelheim GmbH. As the global healthcare CMO market is extremely fragmented with only a few companies dominating the market, the leading companies in this segment have taken up dominant competitive strategies, strong acquisition strategies, and high product development to maintain their lead in the market. Due to the availability of similar technologies and low product

differentiation, the competitive rivalry in the market is expected to rise. Moreover, leading companies are investing on research and development projects to maintain a high level of competitive rivalry.

Browse Full Research Report on Healthcare CMO Market: http://www.transparencymarketresearch.com/healthcare-cmomarket.html Patent Expirations of Drugs to Adversely Impact Demand for Healthcare CMOs In the next few years, several renowned drugs are getting off patent leading to an increase in competition among developers of drugs. Innovative drug developers are collaborating with contract manufacturing organizations to minimize the risk of heavy competition from generic drug developers due to the increasing healthcare R&D cuts by federal banks.

The degeneration in the productive outcomes of R&D and the rising inquiry from regulatory bodies during the approval process of drugs has led to a substantial increase in the demand for CMOs as several leading pharmaceutical companies have started outsourcing their drug development activities.

Furthermore, the need for product innovation and post engineering support service impelled manufacturers to outsource activities such as design, validation, prototype, feasibility tests, concept, and regulatory compliance. Thus, leading companies are seeking synergy with CMOs as a result of patent expirations and decreasing R&D budget.

Emerging Economies to Provide Opportunities for the Development of CMOs in Healthcare Sector Countries such as India, China, and Brazil are emerging as key participants in the global pharmaceutical and medical device market as they own plentiful expertise and technologies for research and development. They also back medical giants in their respective research projects regarding lifesaving drugs and advanced therapies. Thus, these countries are expected to emerge as the major destinations for the outsourcing of medical device and pharmaceuticals.

Global pharmaceutical companies consider these countries to be efficient for research centers and clinical trials. Various CMOs operating outside Asia have successfully attained FDA approvals and credibility for quality standards. The sanction of Good

Manufacturing Practice certificates in emerging economies, especially in Asia, has led to a substantial growth of the healthcare CMO market.

Delayed Delivery of Supplies Could Dent Business Flow to CMOs North America is projected to lead the global market for healthcare CMO with 32.9% followed by Asia-Pacific with a share of 31.2%. The global healthcare CMO market is anticipated to rise at a CAGR of 14.30% between 2013 and 2019 with a market worth of US$246.5 bn by the end of 2019 from a value of US$97.6 bn in 2012.

The review has been based on the findings of a TMR report titled “Healthcare CMO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Browse Full Press Release on Healthcare CMO Market: Press Release

About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative

forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com